Baclofen Suspension
Product Images NDC 71225-140

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Baclofen (NDC 71225-140). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Slayback Pharma Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Baclofen Carton Label (Baclofen Carton Label)

The packaging label for Baclofen Oral Suspension 25 mg per 5 mL (5 mg/mL) Concentrated Formulation by Slayback Pharma LLC. The label states the NDC 71225-140-01 and specifies a 250 mL bottle size. Key details include dosage instructions, storage conditions, a tamper-evident seal note, and a barcode. Manufacturer information lists Bona Pharmaceutical Services Inc. in Mississauga, Canada, and Slayback Pharma LLC in Princeton, NJ.*

FDA Label Image

Baclofen Structure (Baclofen Structure)

Chemical structure diagram showing the molecular formula of Baclofen. The diagram includes a benzene ring substituted with chlorine (Cl) and functional groups representing Baclofen's structure.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.